Indeed, what Kobayashi stated holds true.


    There exists a significant information gap between Yuhiko Ito and Kobayashi.


    At this moment, Yuhiko Ito believed that Kobayashi’s business was unbeatable. To him, acquiring Kobayashi Pharmaceutical felt like seizing a golden opportunity.


    However, Masayoshi Kobayashi and his family members are now aware of Oracle Pharmaceutical’s presence.


    They recognize the rise of Nova Dias in China, particrly in Aurous Hill, where its effectiveness surpasses that of Niranex.<h3 style="background-color:DodgerBlue">


    This realization shifted the perspective of the Kobayashi family when Masayoshi expressed his concerns.


    Initially, they believed that Kobayashi Pharmaceuticals should be valued at a minimum of $20 billion; epting a valuation of $15 billion seemed out of the question.


    Yet, they quickly understood that there are still offers on the table for $15 billion, which is a rare find.


    If Oracle Nova Dias sessfully makes its way eastward into Japan, it could severely diminish the valuation of Kobayashi Pharmaceutical.


    This led everyone to rally in support of Masayoshi Kobayashi’s decision almost unanimously.


    Kobayashi felt a surge of excitement.


    Once the agreement with the Ito family is finalized, Kobayashi Pharmaceutical would instantly receive a $4.5 billion capital infusion, along with $500 million in personal remuneration for him.


    This would catapult him into the realm of the super-rich!


    As for Kobayashi Pharmaceutical, even if it faced bankruptcy in the future, it wouldn’t concern him. The $500 million equates to over 50 billion yen, providing him with afortable lifestyle.


    Thus, he promptly reached out to Yuhiko Ito, urging him toe to Kobayashi Pharmaceutical and finalize the contract without dy.


    Upon receiving this news, Yuhiko Ito was filled with enthusiasm.<fn018e> Updates are released by F?ndNovel</fn018e>


    He believed he was acquiring Kobayashi Pharmaceutical at a bargain price and anticipated earning three to four times more in the future. Without hesitation, he gathered his assistants andwyers and made his way to Kobayashi Pharmaceutical.


    Bothpanies are located near Ginza in Tokyo, within the city’s bustlingmercial district, making the journey only a ten-minute drive.


    Masayoshi Kobayashi, brimming with joy, shared with his family: “Mr. Yuhiko Ito is on his way to sign a contract with us. Once finalized, $4.5 billion will be deposited into our ount, providing us with ample funds to tackle the uing challenges posed by Oracle Pharmaceutical!”


    This announcement brought immediate smiles to everyone’s faces.


    The sum of $4.5 billion is indeed astronomical. With such a financial cushion, even if Kobayashi Pharmaceuticals incurred losses of $100 million annually, they could sustain themselves for 45 years.


    This means that even if Kobayashi Pharmaceutical faces significant challenges, the funds on hand will ensure that its executives can maintain afortable lifestyle for many years toe.


    ……


    At that moment, Takehiko Ito emerged from the opulent Ito family office, exuding confidence as he entered his Lexus.


    Apanying him were two bodyguards and an assistant, thetter being Koichi Tanaka, who had previously assisted Nanako Ito.


    Koichi Tanaka had historically been a trusted confidant of Yuhiko Ito. Recently, he was sent to China to support Nanako in apetition, as Yuhiko wanted someone reliable by her side.